PORTLAND, Ore., April 7, 2015 /PRNewswire/ -- TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the advanced wound care marketplace, through its subsidiary, HemCon Medical Technologies, Inc has received regulatory approval from the China Food and Drug Administration (CFDA) to market and sell products into China. HemCon has commercially entered the market this month by accepting an order through a distributor on the mainland. HemCon's launch into the Chinese market will include its full portfolio of wound care solutions which are protected by patents both in China and throughout the world. Currently the wound care market in China is estimated at $1.2 billion.
Photo - http://photos.prnewswire.com/prnh/20150406/196695
Photo - http://photos.prnewswire.com/prnh/20150406/196696
HemCon has prior experience in the pan-Asian market having successfully established a wound care product line in Japan with their partner ZERIA Pharmaceutical.
Michael Wax, President and CEO said, "With our initial Chinese order in hand, combined with the Chinese government's approval for import of our dressings, we are looking ahead to building a robust business in a rapidly growing market. We have expectations to participate in the fast growing pan-Asian health care industry and specifically the increasing demand for wound care in China."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (OTCQB:TWSI) is a health and wellness company that targets opportunities in the advanced wound care marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contact:
Stephanie Wiegman
Tel: (503) 245-0459
Email
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hemcon-medical-technologies-launches-into-chinese-market-300061723.html
SOURCE TriStar Wellness Solutions, Inc.